Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ERtugliflozin triAl in DIabetes With Preserved or Reduced ejeCtion FrAcTion mEchanistic Evaluation in Heart Failure: "ERADICATE-HF"

NCT03416270 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT03416270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03416270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ERtugliflozin triAl in DIabetes With Preserved or Reduced ejeCtion FrAcTion mEchanistic Evaluation in Heart Failure: "ERADICATE-HF"
Lead sponsor
University Health Network, Toronto
Phase
Phase 2
Overall status
Completed
Start date
June 28, 2018
Completion date
April 14, 2021
Enrollment
34 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, type 2 diabetes mellitus